id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S12449 R46724 |
Halfdanarson (Controls exposed to FGA), 2022 | Autism spectrum disorder (ASD) at age 1 or older (ICD-10 diagnosis of F84.0, F84.1 or F84) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.86 [0.66;1.13] C excluded (control group) |
110/7,752 113/6,896 | 223 | 7,752 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12448 R46722 |
Halfdanarson (Controls unexposed, NOS), 2022 | Autism spectrum disorder (ASD) at age 1 or older (ICD-10 diagnosis of F84.0, F84.1 or F84) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 1.26 [1.03;1.54] | 110/7,752 38,436/4,308,620 | 38,546 | 7,752 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12466 R46916 |
Straub, 2022 | Autism spectrum disorder (ASD) (≥ 2 dates with ICD-9 Dx 299.xx) - By 8 years of age | 2nd and/or 3rd trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 1.05 [0.82;1.33] | 90/9,390 13,429/3,309,095 | 13,519 | 9,390 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12454 R46737 |
Wang a (Controls exposed to FGA), 2021 | Autism spectrum disorder (ASD) - (ICD-9-CM: 299) - At least 3 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No |
0.37 [0.11;1.29] C excluded (control group) |
3/199 16/405 | 19 | 199 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12453 R46733 |
Wang a (Controls unexposed, NOS), 2021 | Autism spectrum disorder (ASD) - (ICD-9-CM: 299) - At least 3 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 0.71 [0.23;2.21] C | 3/199 8,688/410,545 | 8,691 | 199 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12458 R47070 |
Yeh, 2021 | Autism spectrum disorder (ASD - at least twice outpatient visits within each year for ICD-9 code: 299) - At 0-10 years old | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 1.96 [0.21;18.32] | -/45 -/5,243 | - | 45 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 1.16 [1.00;1.35] | 60,756 | 17,386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, NOS; 2: Controls unexposed, NOS;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 12454, 12449